DaVita HealthCare Partners(DVA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

DVA DaVita HealthCare Partners

Pre-Mkt 12-29 04:51:35 EST

113.98

-0.43

-0.38%

High114.52	Low113.42	Vol575.35K
Open113.87	D1 Closing114.41	Amplitude0.96%
Mkt Cap8.05B	Tradable Cap3.97B	Total Shares70.60M
T/O65.52M	T/O Rate1.65%	Tradable Shares34.79M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"DVA","market":"US","secType":"STK","nameCN":"DaVita HealthCare Partners","latestPrice":113.98,"timestamp":1766782800000,"preClose":114.41,"halted":0,"volume":575354,"delay":0,"floatShares":34790800,"shares":70600000,"eps":9.764844,"marketStatus":"Pre-Mkt","change":-0.43,"latestTime":"12-29 04:51:35 EST","open":113.87,"high":114.5234,"low":113.42,"amount":65522224.880736,"amplitude":0.009644,"askPrice":115,"askSize":4,"bidPrice":103.62,"bidSize":100,"shortable":3,"etf":0,"ttmEps":9.764844,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1767018600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":815029200000,"exchange":"NYSE","adjPreClose":113.98,"postHourTrading":{"tag":"盘后","latestPrice":113.98,"preClose":113.98,"latestTime":"18:05 EST","volume":88832,"amount":10125073.21,"timestamp":1766790349439},"volumeRatio":0.733982991135091,"impliedVol":0.3146,"impliedVolPercentile":0.2289},"requestUrl":"/m/hq/s/DVA","defaultTab":"news","newsList":[{"id":"2590515002","title":"Press Release: DaVita Names New Leaders to Accelerate Care Transformation","url":"https://stock-news.laohu8.com/highlight/detail?id=2590515002","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590515002?lang=en_us&edition=fundamental","pubTime":"2025-12-11 21:00","pubTimestamp":1765458000,"startTime":"0","endTime":"0","summary":"Appointments of Chief People Officer and Chief Strategy Officer underscore commitment to innovation and people-first approach. DENVER, Dec. 11, 2025 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announced two key additions to its executive leadership team: Stephanie Hendrickson has been named Chief People Officer  and Steve Phillips will serve as Chief Strategy Officer , effective immediately. Both leaders bring more than a decade of proven success at DaVita and deep expertise that will help shape the company's next chapter of growth and innovation.\"We're at an exciting inflection point in healthcare, where new technologies are rapidly transforming care and improving outcomes,\" said Phillips. \"I'm honored to help shape meaningful transformation in kidney care and chronic disease managemen","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","BK4585","DVA","BK4588","BK4196","AAQC"],"gpt_icon":0},{"id":"2586045314","title":"BRIEF-Davita Inc - On Nov 24, Entered Into Eighth Amendment To Credit Agreement Dated As Of August 12, 2019 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2586045314","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586045314?lang=en_us&edition=fundamental","pubTime":"2025-11-26 06:10","pubTimestamp":1764108644,"startTime":"0","endTime":"0","summary":"BRIEF-Davita Inc - On Nov 24, Entered Into Eighth Amendment To Credit Agreement Dated As Of August 12, 2019 - SEC FilingNov 25  - DaVita Inc DVA.N:DAVITA INC - ON NOV 24, ENTERED INTO EIGHTH AMENDMENT TO CREDIT AGREEMENT DATED AS OF AUGUST 12, 2019 - SEC FILINGDAVITA INC - AMENDMENT PROVIDES FOR NEW FIVE-YEAR SECURED TERM LOAN A FACILITY UP TO $2 BILLION - SEC FILINGDAVITA INC - AMENDMENT PROVIDES FOR NEW FIVE-YEAR SECURED REVOLVING CREDIT FACILITY UP TO $1.5 BILLION - SEC FILINGSource text: [ID:n0001206774-25-000750]Further company coverage: DVA.N ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nFWN3X10IP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","BK4196","DVA","BK4588","BK4585"],"gpt_icon":0},{"id":"2586401017","title":"DaVita Inc - Amendment Provides for New Five-Year Secured Term Loan a Facility up to $2 Bln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2586401017","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586401017?lang=en_us&edition=fundamental","pubTime":"2025-11-26 06:02","pubTimestamp":1764108142,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nFWN3X10IP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DVA","BK4588","BK4559","BK4585","BK4196"],"gpt_icon":0},{"id":"2586010484","title":"DaVita Inc - on Nov 24, Entered Into Eighth Amendment to Credit Agreement Dated as of August 12, 2019 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2586010484","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586010484?lang=en_us&edition=fundamental","pubTime":"2025-11-26 06:02","pubTimestamp":1764108142,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nFWN3X10IP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4559","BK4196","BK4588","DVA","BK4585"],"gpt_icon":0},{"id":"2586010401","title":"DaVita Inc - Amendment Provides for New Five-Year Secured Revolving Credit Facility up to $1.5 Bln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2586010401","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586010401?lang=en_us&edition=fundamental","pubTime":"2025-11-26 06:02","pubTimestamp":1764108142,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nFWN3X10IP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","BK4588","BK4585","BK4559","DVA"],"gpt_icon":0},{"id":"2586499324","title":"Alphabet Stock Is a Berkshire Win. The Gain So Far May Be 40%. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2586499324","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586499324?lang=en_us&edition=fundamental","pubTime":"2025-11-25 00:49","pubTimestamp":1764002940,"startTime":"0","endTime":"0","summary":"Berkshire Hathaway was late in buying Alphabet, but it is scoring nonetheless given the sharp rally in the operator of the leading search engine.Berkshire bought 17.85 million of Alphabet's voting shares in the third quarter for what Barron's estimates was around $4 billion, or an average price of $225 a share. Recent moves in the stock suggest that Berkshire already is showing a 40% gain on its new investment.Berkshire's Alphabet stake is now worth about $5.6 billion, resulting in what Barron's estimates is a profit of more than $1.5 billion.Berkshire Hathaway CEO Warren Buffett and former vice chairman Charlie Munger praised Alphabet at the 2017 Berkshire annual meeting, when the stock traded around $45, but the company waited until 2025 to buy shares.At the 2017 Berkshire annual meeting, Buffett talked about Alphabet's Google business in relation to Geico, Berkshire's auto insurer. \"","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4507","BRK.B","LU0985489474.SGD","LU0068578508.USD","SIRI","LU2211815571.USD","LU2471134952.CNY","LU0203201768.USD","LU1868836757.USD","LU1880398554.USD","LU2087625088.SGD","SG9999014898.SGD","GOOG","USJW.SI","IE0004086264.USD","IE00B19Z3581.USD","LU0289941410.SGD","DVA","LU1066053197.SGD","BK4598","LU0820561818.USD","LU1032955483.USD","LU0985320562.USD","LU1815333072.USD","IE00BFSS7M15.SGD","BK4514","LU2097344431.USD","LU0648000940.SGD","BRK.A","LU2471134523.USD","LU1868837136.USD","LU1629891620.HKD","LU0433182093.SGD","GOOGL","LU0648001328.SGD","LU2471134879.HKD","LU1066051811.HKD","LU1196500208.SGD","LU2242650005.HKD","LU2125154778.USD","IE00BMPRXR70.SGD","LU1868836591.USD","LU0545039389.USD","LU2720916845.USD","SG9999001077.SGD","LU1548497426.USD","LU0957808578.USD","LU1267930490.SGD","LU2097344357.USD","SG9999015952.SGD"],"gpt_icon":1},{"id":"2583650123","title":"Is Now the Right Time to Reconsider DaVita After Its 18.9% Drop in 2025?","url":"https://stock-news.laohu8.com/highlight/detail?id=2583650123","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583650123?lang=en_us&edition=fundamental","pubTime":"2025-11-16 06:16","pubTimestamp":1763244988,"startTime":"0","endTime":"0","summary":"If you’ve ever wondered whether DaVita is trading at a bargain or sitting above its true worth, you’re not alone. Figuring out the real value behind the ticker is on every investor’s mind right now.\nThe stock has seen plenty of movement lately, with shares slipping 1.7% over the last week, 3.5% over the past month, and taking a larger 18.9% dip year-to-date. Yet over the last three years, DaVita has actually surged 72.0%.\nSome of this volatility follows ongoing chatter about healthcare...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice1-main-header/1585186661957"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-dva/davita/news/is-now-the-right-time-to-reconsider-davita-after-its-189-dro","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-dva/davita/news/is-now-the-right-time-to-reconsider-davita-after-its-189-dro","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DVA","DCF","BK4196","BK4559","BK4585","BK4588"],"gpt_icon":0},{"id":"2583845956","title":"DaVita Inc. CFO to Join Wolfe Research Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2583845956","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583845956?lang=en_us&edition=fundamental","pubTime":"2025-11-15 05:17","pubTimestamp":1763155047,"startTime":"0","endTime":"0","summary":"DaVita Inc. will participate in a fireside chat at the Wolfe Research Healthcare Conference on Monday, November 17, 2025, with chief financial officer Joel Ackerman representing the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DaVita Inc. published the original content used to generate this news brief via PR Newswire  on November 14, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDLTLr1C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","BK4588","DVA","BK4585","BK4196"],"gpt_icon":0},{"id":"2582318747","title":"DaVita Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2582318747","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582318747?lang=en_us&edition=fundamental","pubTime":"2025-11-12 06:19","pubTimestamp":1762899540,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of DaVita Inc.  rallied 1.75% to $122.27 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.21% to 6,846.61 and the Dow Jones Industrial Average  rising 1.18% to 47,927.96.DaVita Inc. closed 31.92% below its 52-week high of $179.60, which the company reached on January 31st.The stock underperformed when compared to some of its competitors Tuesday, as UnitedHealth Group Inc.  rose 1.83% to $327.45, Icon PLC  rose 3.64% to $163.42, and Quest Diagnostics Inc.  rose 2.46% to $188.85.Trading volume  eclipsed its 50-day average volume of 830,891.Data source: Dow Jones Market Data, FactSet. Data compiled November 11, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","BK4566","LU0211326755.USD","LU2552382132.HKD","LU0175139822.USD","LU0289961442.SGD","LU0114720955.EUR","LU0128525929.USD","BK4567","LU2087625088.SGD","IE00B19Z8X17.USD","LU0795875086.SGD","LU2125154778.USD","IE00B7KXQ091.USD","LU0426417589.USD","LU0289739343.SGD","LU2023251221.USD","LU0943347566.SGD","LU1814569148.SGD","IE00B19Z9Z06.USD","LU0234572021.USD","IE000M9KFDE8.USD","IE00BWXC8680.SGD","LU0354030438.USD","IE00BFTCPJ56.SGD","LU1551013342.USD","DVA","LU0029864427.USD","LU1267930573.SGD","LU0511384066.AUD","IE00BFSS7M15.SGD","LU0211326839.USD","SGXZ57979304.SGD","DGX","LU0354030511.USD","LU0683600562.USD","LU1057294990.SGD","LU0820562030.AUD","LU0965509010.AUD","IE00B19Z9505.USD","LU2133065610.SGD","LU0187121727.USD","ICLR","LU0882574055.USD","LU1732800096.USD","LU0345770308.USD","LU0861579265.USD","LU0345770993.USD","SG9999001176.USD"],"gpt_icon":1},{"id":"2580172249","title":"DaVita (DVA) Gets a Hold from Truist Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2580172249","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580172249?lang=en_us&edition=fundamental","pubTime":"2025-11-04 02:15","pubTimestamp":1762193752,"startTime":"0","endTime":"0","summary":"Truist Financial analyst David S Macdonald maintained a Hold rating on DaVita today and set a price target of $140.00. The company’s shares opened ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/davita-dva-gets-a-hold-from-truist-financial-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/davita-dva-gets-a-hold-from-truist-financial-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","DVA","BK4585","BK4559","BK4196"],"gpt_icon":0},{"id":"2580489062","title":"DaVita Is Maintained at Hold by TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2580489062","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580489062?lang=en_us&edition=fundamental","pubTime":"2025-11-04 00:33","pubTimestamp":1762187580,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DVA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 03, 2025 11:33 ET (16:33 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COWN","BK4127","BK4566","BK4559","TD","BK4196","DVA","BK4207","BK4588","BK4585"],"gpt_icon":0},{"id":"2580269788","title":"U.S. RESEARCH ROUNDUP- Crowdstrike, Guardant Health, Palantir Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2580269788","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580269788?lang=en_us&edition=fundamental","pubTime":"2025-11-03 15:35","pubTimestamp":1762155304,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP- Crowdstrike, Guardant Health, Palantir TechnologiesNov 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nL4N3WF0CQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARI","COLB","ABBV","COST","LU1023059063.AUD","DDOG","CI","DVA","FLS","FSUN","CL","CAH","AVB","EXE","FBNC","GH","IE00BK4W5L77.USD","CWH","FFWM","ATEC","LU2463526074.USD","CHTR","ABR","LU2360032135.SGD","ARE","BLDR","DAN","EW","ATR","LU2361044949.HKD","CVS","FHI","AAMI","OWL","AMP","CG","LU1127390331.HKD","CHYM","FMBH","EHC","LU0079474960.USD","LU1934455863.HKD","LU0738911758.USD","CBOE","CRWD","CHD","CMA","ALH","AR"],"gpt_icon":1},{"id":"2580250256","title":"DaVita Inc : TD Cowen Cuts Target Price to $133 From $154","url":"https://stock-news.laohu8.com/highlight/detail?id=2580250256","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580250256?lang=en_us&edition=fundamental","pubTime":"2025-11-03 13:38","pubTimestamp":1762148322,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nFWN3WC3IN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","BK4559","DVA","BK4588","BK4585"],"gpt_icon":0},{"id":"1151161669","title":"DVA Commercialization Advances: Shandong Dawn Polymer's Net Profit Projected to Grow from 140M to 751M in 3 Years?","url":"https://stock-news.laohu8.com/highlight/detail?id=1151161669","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151161669?lang=en_us&edition=fundamental","pubTime":"2025-10-31 19:11","pubTimestamp":1761909078,"startTime":"0","endTime":"0","summary":"Shandong Dawn Polymer Co., Ltd. (002838) recently drew significant market attention—though this time due to a sharp pullback. On October 30, its shares fell over 9%, followed by a 2.35% rebound on...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","002838","BK0220","BK4196","DVA","BK4588","BK4585"],"gpt_icon":0},{"id":"2579170848","title":"DaVita Inc. Stock Falls 6.2%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2579170848","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579170848?lang=en_us&edition=fundamental","pubTime":"2025-10-31 04:35","pubTimestamp":1761856500,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of DaVita Inc. shed 6.2% to $118.75 on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 1.0% to 6,822.34 and Dow Jones Industrial Average falling 0.2% to 47,522.12.This was the stock's second consecutive day of losses.DaVita Inc. closed 33.9% below its 52-week high of $179.60, which the company reached on January 31st.The stock underperformed when compared to some of its peers, as UnitedHealth Group Inc. fell 3.0% to $344.75, Icon PLC fell 0.4% to $165.33, and Quest Diagnostics Inc. rose 0.55% to $175.75.Trading volume totaled 2.5 million, compared to the 50-day average of 728,509.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","DVA","BK4585","BK4559","BK4196"],"gpt_icon":0},{"id":"1107003362","title":"Stock Track | DaVita Plummets 5.05% as Multiple Analysts Cut Price Targets","url":"https://stock-news.laohu8.com/highlight/detail?id=1107003362","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107003362?lang=en_us&edition=fundamental","pubTime":"2025-10-31 03:14","pubTimestamp":1761851649,"startTime":"0","endTime":"0","summary":"DaVita HealthCare Partners (DVA) saw its stock plummet by 5.05% during intraday trading on Thursday, as several prominent analysts lowered their price targets for the company. The healthcare provider...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["DVA"],"gpt_icon":0},{"id":"2579124754","title":"DaVita Is Maintained at Equal-Weight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2579124754","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579124754?lang=en_us&edition=fundamental","pubTime":"2025-10-31 00:10","pubTimestamp":1761840600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DVA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 30, 2025 12:10 ET (16:10 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4196","BK4585","DVA","BK4559"],"gpt_icon":0},{"id":"2579124836","title":"Barclays Adjusts Price Target on DaVita to $143 From $149","url":"https://stock-news.laohu8.com/highlight/detail?id=2579124836","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579124836?lang=en_us&edition=fundamental","pubTime":"2025-10-30 22:44","pubTimestamp":1761835498,"startTime":"0","endTime":"0","summary":"DaVita (DVA) has an average rating of hold and mean price target of $147, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and rese","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","DVA","BK4585","BK4559","BK4196"],"gpt_icon":0},{"id":"2579145299","title":"Truist Financial Remains a Hold on DaVita (DVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2579145299","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579145299?lang=en_us&edition=fundamental","pubTime":"2025-10-30 19:59","pubTimestamp":1761825558,"startTime":"0","endTime":"0","summary":"In a report released today, David S Macdonald from Truist Financial maintained a Hold rating on DaVita. The company’s shares closed yesterday at $1...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/truist-financial-remains-a-hold-on-davita-dva-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/truist-financial-remains-a-hold-on-davita-dva-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4196","DVA","BK4559","BK4585"],"gpt_icon":0},{"id":"2579113240","title":"DaVita Inc. : Barclays Cuts Target Price to $143 From $149","url":"https://stock-news.laohu8.com/highlight/detail?id=2579113240","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579113240?lang=en_us&edition=fundamental","pubTime":"2025-10-30 17:52","pubTimestamp":1761817978,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nAZN4Q9X8L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DVA","BK4196","BK4585","BK4559","BK4588"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.davita.com","stockEarnings":[{"period":"1week","weight":-0.0106},{"period":"1month","weight":-0.051},{"period":"3month","weight":-0.1286},{"period":"6month","weight":-0.1955},{"period":"1year","weight":-0.2672},{"period":"ytd","weight":-0.2378}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":0.0156},{"period":"3month","weight":0.043},{"period":"6month","weight":0.1226},{"period":"1year","weight":0.148},{"period":"ytd","weight":0.1778}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.","yearOnYearQuotes":[{"month":1,"riseRate":0.533333,"avgChangeRate":0.004213},{"month":2,"riseRate":0.466667,"avgChangeRate":-0.022462},{"month":3,"riseRate":0.566667,"avgChangeRate":0.020909},{"month":4,"riseRate":0.633333,"avgChangeRate":0.026145},{"month":5,"riseRate":0.6,"avgChangeRate":0.019027},{"month":6,"riseRate":0.6,"avgChangeRate":0.045334},{"month":7,"riseRate":0.533333,"avgChangeRate":-0.007824},{"month":8,"riseRate":0.433333,"avgChangeRate":-0.005884},{"month":9,"riseRate":0.566667,"avgChangeRate":0.017103},{"month":10,"riseRate":0.5,"avgChangeRate":0.001552},{"month":11,"riseRate":0.612903,"avgChangeRate":0.050929},{"month":12,"riseRate":0.580645,"avgChangeRate":0.040615}],"exchange":"NYSE","name":"DaVita HealthCare Partners","nameEN":"DaVita HealthCare Partners"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"DaVita HealthCare Partners(DVA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest DaVita HealthCare Partners(DVA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"DaVita HealthCare Partners,DVA,DaVita HealthCare Partners股票,DaVita HealthCare Partners股票老虎,DaVita HealthCare Partners股票老虎国际,DaVita HealthCare Partners行情,DaVita HealthCare Partners股票行情,DaVita HealthCare Partners股价,DaVita HealthCare Partners股市,DaVita HealthCare Partners股票价格,DaVita HealthCare Partners股票交易,DaVita HealthCare Partners股票购买,DaVita HealthCare Partners股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"DaVita HealthCare Partners(DVA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest DaVita HealthCare Partners(DVA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction